REQUEST A DEMO
Total
USD $0.00
Search more companies

PCL Inc. (South Korea)

Main Activities: Surgical and Medical Instrument Manufacturing
Full name: PCL Inc. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

PCL Inc. is an enterprise in South Korea, with the main office in Seoul. The enterprise currently operates in the Surgical and Medical Instrument Manufacturing sector. It was first established on February 12, 2008. 30 (2024) employees currently work for PCL Inc.. In Q3C2025, the company reported a net sales revenue increase of 174.24%. Over the same period, its total assets decreased by 74.3%. The net profit margin of PCL Inc. increased by 447.98% in 2025.

Headquarters
701, 99, Digital-Ro 9-Gi, Geumcheon-Gu
Seoul; Seoul;

Contact Details: Purchase the PCL Inc. report to view the information.

Website: http://www.pclchip.com

Basic Information
Total Employees:
Purchase the PCL Inc. report to view the information.
Outstanding Shares:
Purchase the PCL Inc. report to view the information.
Registered Capital:
Purchase the PCL Inc. report to view the information.
Financial Auditors:
Purchase the PCL Inc. report to view the information.
Incorporation Date:
February 12, 2008
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
34.8%
Purchase this report to view the information.
2.5%
Purchase this report to view the information.
0.9%
Subsidiaries
피씨엘㈜
Company Performance
Financial values in the chart are available after PCL Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
174.24%
Total Operating Revenue
114.52%
Operating Profit
56.61%
EBITDA
11.94%
Net Profit/Loss for the Period
54.36%
Total Assets
-74.3%
Total Equity
-94.77%
Operating Profit Margin
436.32%
Net Profit Margin
447.98%
Return on Equity (ROE)
-143.49%
Debt / Equity
300.3%
Quick Ratio
-1.27%
Cash Ratio
-0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?